APT(SH:688617) Sou Hu Cai Jing·2025-04-01 11:53Company Overview - Huatai Medical closed at 407.57 yuan, up 5.23%, with a rolling PE ratio of 58.75, marking a new low in 119 days, and a total market capitalization of 39.568 billion yuan [1] - The company ranks 97th in the medical device industry, which has an average PE ratio of 46.46 and a median of 33.07 [1] Financial Performance - For the third quarter of 2024, Huatai Medical reported revenue of 1.525 billion yuan, a year-on-year increase of 25.63%, and a net profit of 528 million yuan, up 30.97%, with a gross profit margin of 72.69% [1] Shareholding Structure - As of the third quarter of 2024, 479 institutions hold Huatai Medical shares, including 478 funds and 1 brokerage, with a total holding of 30.0891 million shares valued at 11.203 billion yuan [1] Product and Market Position - Huatai Medical specializes in the research, production, and sales of cardiovascular interventional medical devices, with key products including electrophysiology and vascular intervention devices [1] - The company is a leading domestic manufacturer in the electrophysiology market, having launched the first domestically approved electrophysiology electrode catheter and radiofrequency ablation electrode catheter [1]